Chris D. Poole

4.0k total citations · 1 hit paper
73 papers, 3.0k citations indexed

About

Chris D. Poole is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Physiology. According to data from OpenAlex, Chris D. Poole has authored 73 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Epidemiology and 14 papers in Physiology. Recurrent topics in Chris D. Poole's work include Diabetes Management and Research (16 papers), Diabetes Treatment and Management (16 papers) and Pain Mechanisms and Treatments (10 papers). Chris D. Poole is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes Treatment and Management (16 papers) and Pain Mechanisms and Treatments (10 papers). Chris D. Poole collaborates with scholars based in United Kingdom, United States and Netherlands. Chris D. Poole's co-authors include Craig J. Currie, Christopher Ll. Morgan, Marc Evans, Sara Jenkins‐Jones, John R. Peters, Aodán Tynan, Oswaldo L. Bracco, Robert J. Heine, Phil McEwan and Edwin Gale and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Chris D. Poole

73 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

2010 615 citations Craig J. Currie, John R. Peters et al. The Lancet profile →

Peers

Countries citing papers authored by Chris D. Poole

Since Specialization

Citations

This map shows the geographic impact of Chris D. Poole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris D. Poole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris D. Poole more than expected).

Fields of papers citing papers by Chris D. Poole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris D. Poole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris D. Poole. The network helps show where Chris D. Poole may publish in the future.

Co-authorship network of co-authors of Chris D. Poole

This figure shows the co-authorship network connecting the top 25 collaborators of Chris D. Poole. A scholar is included among the top collaborators of Chris D. Poole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris D. Poole. Chris D. Poole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational Study 2021 ·Clinical Therapeutics ·Christopher Ll. Morgan, Sara Jenkins‐Jones, Roger Knaggs, Craig J. Currie, (unknown), Chris D. Poole, Ellen Berni	1
2	Evaluation of the cost-effectiveness of rifaximin-α for the management of patients with hepatic encephalopathy in the United Kingdom 2018 ·Current Medical Research and Opinion ·Ellen Berni, Daniel Murphy, James Whitehouse, Pete Conway, Paola Maggio, Craig J. Currie, Chris D. Poole	6
3	Prescription of DPP-4 Inhibitors to Patients With Adult Type 2 Diabetes Mellitus and Creatinine Clearance >50 mL/min: The UK Primary Care Experience 2018 ·Clinical Therapeutics ·(unknown), Brendan J. Barrett, Michael Busse, (unknown), Chris D. Poole	1
4	A Systematic Literature Review And Network Meta-Analysis of Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for The Treatment of Painful Diabetic Peripheral Neuropathy 2015 ·Value in Health ·(unknown), M. Charokopou, Chris D. Poole, M. Treur	2
5	Use of 5% lidocaine medicated plasters for the treatment of pain in routine hospital practice: patient reported pain, functioning and satisfaction 2014 ·Current Medical Research and Opinion ·(unknown), Christopher Ll. Morgan, (unknown), Chris D. Poole	8
6	Cost-Effectiveness of Capsaicin 8% Patch (Qutenzatm) Compared With Pregabalin for the Treatment of Patients With Peripheral Neuropathic Pain (Pnp) In Scotland 2014 ·Value in Health ·S. Patel, David Trueman, Anthony Bentley, Chris D. Poole, (unknown)	3
7	Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy 2014 ·Health and Quality of Life Outcomes ·Chris D. Poole, Christian Bannister, (unknown), Jens Strodl Andersen, Craig J. Currie	10
8	Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer 2013 ·Journal of Clinical Oncology ·Ignace Vergote, Agustin A. García, John P. Micha, Charles H. Pippitt, Johanna C. Bendell, Daniel L. Spitz, Nicholas Reed, G. Dark, Paula M. Fracasso, Emad Ibrahim, Vincent Armenio, Linda Duska, Chris D. Poole, Christine Gennigens, Luc Dirix, Abraham C.F. Leung, Carol Zhao, Raoudha Soufi‐Mahjoubi, Gordon Rustin	34
9	Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study 2013 ·BMJ Open ·Christopher Ll. Morgan, David R. Owens, (unknown), (unknown), Sara Jenkins‐Jones, Chris D. Poole, Craig J. Currie	20
10	Treatment of neuropathic pain with the capsaicin 8% patch: Quantitative sensory testing (QST) in a prospective observational study identifies potential predictors of response to capsaicin 8% patch treatment 2013 ·Scandinavian Journal of Pain ·Burkhard Gustorff, Chris D. Poole, (unknown), (unknown), Rudolf Likar	20
11	Evaluation of the Cost-Effectiveness of the Capsaicin Patch Qutenzatm for the Treatment of Peripheral Neuropathic Pain in the United Kingdom 2013 ·Value in Health ·David Trueman, Chris D. Poole, (unknown), Isaac Odeyemi, (unknown)	1
12	The impact of treatment non-compliance on mortality in people with type 1 diabetes 2012 ·Journal of Diabetes and its Complications ·Craig J. Currie, Mark Peyrot, Christopher Ll. Morgan, Chris D. Poole, Sara Jenkins‐Jones, Richard R. Rubin, Christopher M. Burton, Marc Evans	49
13	The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes 2012 ·Diabetes Care ·Craig J. Currie, Mark Peyrot, Christopher Ll. Morgan, Chris D. Poole, Sara Jenkins‐Jones, Richard R. Rubin, Christopher M. Burton, Marc Evans	205
14	Omega-3 Fatty Acids and Mortality Outcome in Patients With and Without Type 2 Diabetes After Myocardial Infarction: A Retrospective, Matched-Cohort Study 2012 ·Clinical Therapeutics ·Chris D. Poole, Julian Halcox, Sara Jenkins‐Jones, (unknown), (unknown), Kausik K. Ray, Craig J. Currie	30
15	Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study breakdown → 2010 ·The Lancet ·Craig J. Currie, John R. Peters, Aodán Tynan, Marc Evans, Robert J. Heine, Oswaldo L. Bracco, (unknown), Chris D. Poole	615
16	An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial 2008 ·Journal of Crohn s and Colitis ·Mark P. Connolly, (unknown), Craig J. Currie, Chris D. Poole, Simon Travis	10
17	The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study 2008 ·BMC Musculoskeletal Disorders ·Chris D. Poole, Pete Conway, Alan Reynolds, Craig J. Currie	10
18	An evaluation of the association between systemic inflammation – as measured by C-reactive protein – and hospital resource use 2007 ·Current Medical Research and Opinion ·Chris D. Poole, Pete Conway, Craig J. Currie	4
19	The impact of the overactive bladder on health‐related utility and quality of life 2006 ·British Journal of Urology ·Craig J. Currie, (unknown), Chris D. Poole, Isaac Odeyemi, (unknown), Christopher Ll. Morgan	52
20	The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy 2006 ·Diabetologia ·Craig J. Currie, Chris D. Poole, (unknown), Christopher Ll. Morgan, (unknown), Matthew D. Rousculp, (unknown), John R. Peters	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact